Exploring the Role of RGD-Recognizing Integrins in Cancer.

Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H. · 2017

Read Exploring the Role of RGD-Recognizing Integrins in Cancer. by Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5615331.txt.

Description

Nieberler and co-authors review a family of cell-surface receptors in Cancers. Integrins link cells to their surroundings and pass signals both ways. Eight of them recognize a tiny three-part motif, RGD, in matrix proteins. Those eight help cancers grow and spread.

Because the receptors sit on the cell surface, drugs can reach them. Chemists have built small peptide-like blockers for single subtypes. Others carry glowing or radioactive tags for imaging tumors. Still others coat nanoparticles so poisons ride straight to cancer cells. Trials are testing whether blocking these receptors slows adhesion and invasion. Knowing each subtype's own job is the key to clean intervention. The review sorts the subtypes and their ligands. Readers get a target map for personalized cancer work.

Catalog record

CREATORNieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE127 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5615331

Browse the full library · About the Tower of Babel